These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28679419)

  • 1. Improvement of left ventricular ejection fraction in revascularized postmyocardial patients: indication for statistical fallacy.
    Reibis R; Salzwedel A; Bonaventura K; Völler H; Wegscheider K
    BMC Res Notes; 2017 Jul; 10(1):244. PubMed ID: 28679419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility.
    Sjöblom J; Muhrbeck J; Witt N; Alam M; Frykman-Kull V
    Circulation; 2014 Aug; 130(9):743-8. PubMed ID: 25074505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction?
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Europace; 2014 Sep; 16(9):1315-21. PubMed ID: 24599939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
    Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
    Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural History and Implantable Cardioverter-Defibrillator Implantation After Revascularization for Stable Coronary Artery Disease With Depressed Ejection Fraction.
    Lewis GF; Harless AC; Vazquez L; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Morin DP
    Clin Cardiol; 2015 Dec; 38(12):715-9. PubMed ID: 26442702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation.
    Fan X; Hua W; Xu Y; Ding L; Niu H; Chen K; Xu B; Zhang S
    Heart; 2014 Aug; 100(16):1242-9. PubMed ID: 24895352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction, and preserved left ventricular ejection fraction.
    Mondésert B; Khairy P; Schram G; Shohoudi A; Talajic M; Andrade JG; Dubuc M; Guerra PG; Macle L; Roy D; Dyrda K; Thibault B; Barrero M; Diaz A; Kouz S; McNicoll S; Nowakowska D; Rivard L
    Heart Rhythm; 2016 Jun; 13(6):1221-7. PubMed ID: 26806581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
    Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
    Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of sudden cardiac death risk in the very early postmyocardial infarction period.
    Daoud EG; Hummel JD; Rhodes TE
    Curr Opin Cardiol; 2010 May; 25(3):253-61. PubMed ID: 22393566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.
    Pertzov B; Novack V; Zahger D; Katz A; Amit G
    Int J Cardiol; 2013 Jun; 166(2):421-4. PubMed ID: 22100182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres N; Hindricks G
    Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.